advertisement

---

İrkeç M 11

Showing records 1 to 11 | Display all abstracts from İrkeç M

126128 Investigational drugs for glaucoma: novel mechanistic approaches of preclinical agents
İrkeç M
Expert Opinion on Investigational Drugs 2025; 34: 231-243

---

125600 Contact Lenses for Visual Habilitation in Infantile Aphakia: Long-Term Visual Outcomes and Factors Affecting Treatment Success
Sengor T; Aksoy S
Eye Contact Lens 2025; 51: 269-276

---

126128 Investigational drugs for glaucoma: novel mechanistic approaches of preclinical agents
Konstas AG
Expert Opinion on Investigational Drugs 2025; 34: 231-243

---

125600 Contact Lenses for Visual Habilitation in Infantile Aphakia: Long-Term Visual Outcomes and Factors Affecting Treatment Success
Karacorlu M
Eye Contact Lens 2025; 51: 269-276

---

126128 Investigational drugs for glaucoma: novel mechanistic approaches of preclinical agents
Holló G
Expert Opinion on Investigational Drugs 2025; 34: 231-243

---

125600 Contact Lenses for Visual Habilitation in Infantile Aphakia: Long-Term Visual Outcomes and Factors Affecting Treatment Success
Kurna SA
Eye Contact Lens 2025; 51: 269-276

---

126128 Investigational drugs for glaucoma: novel mechanistic approaches of preclinical agents
Dikmetaş Ö
Expert Opinion on Investigational Drugs 2025; 34: 231-243

---

125600 Contact Lenses for Visual Habilitation in Infantile Aphakia: Long-Term Visual Outcomes and Factors Affecting Treatment Success
Atakan TG
Eye Contact Lens 2025; 51: 269-276

---

126128 Investigational drugs for glaucoma: novel mechanistic approaches of preclinical agents
Algedik Tokyürek MÖ
Expert Opinion on Investigational Drugs 2025; 34: 231-243

---

125600 Contact Lenses for Visual Habilitation in Infantile Aphakia: Long-Term Visual Outcomes and Factors Affecting Treatment Success
İrkeç M
Eye Contact Lens 2025; 51: 269-276

---

126128 Investigational drugs for glaucoma: novel mechanistic approaches of preclinical agents
Bozkurt B
Expert Opinion on Investigational Drugs 2025; 34: 231-243

---